Shares of Fluidigm (FLDM-4.99%) rose over 58% today after the company announced it was selected to receive up to $37 million from the National Institutes of Health through the agency's Rapid ...
License for De Novo Software’s FCS Express 7 Flow to be Provided to Customers Purchasing Fluidigm Helios and Hyperion Imaging Systems SOUTH SAN FRANCISCO, Calif., Aug. 04, 2020 (GLOBE NEWSWIRE) -- ...
Fluidigm might be the company to finally offer an alternative to the painful nasal swabs used to test patients for COVID-19. On Wednesday, the California-based small-cap diagnostics company received ...
More than 100 Academic, Pharmaceutical and Biotech Companies Select Maxpar Immune Profiling Panels Using CyTOF Technology to Accelerate Translational and Clinical Research SOUTH SAN FRANCISCO, Calif., ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--In the rarified world of protein crystal hunters, Fluidigm’s TOPAZ® system is the tool that has helped researchers solve the structures of proteins from ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Fluidigm Corporation (NAS: FLDM) today announced that Gerhard F. Burbach has been appointed to Fluidigm's Board of Directors. Mr. Burbach will also join ...
When Fluidigm announced in late August that its Advanta coronavirus diagnostic test had received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA), its stock briefly ...
Fluidigm, a finalist in the 2021 Medical Design Excellence Awards, is about to undergo some significant changes. The South San Francisco, CA-based company will not only see its name changed to ...
Fluidigm Introduces Its Most Advanced Genomic Analysis System – The BioMark™ HD Real-Time PCR System
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm today introduced the new BioMark™ HD Real-time PCR System, the company’s most advanced instrument for genomic analysis ever. The BioMark HD ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Fluidigm Corporation (NAS: FLDM) today announced its C1™ Single-Cell Auto Prep System has been selected as a recipient of a 2012 GOOD DESIGN™ Award ...
Fluidigm (FLDM), a developer of microfluidic systems, priced its IPO on February 9, at the low end of its range at $13.5 per share, and gave a first-day return of 3.9%. We develop, manufacture and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results